The effect of omalizumab treatment on severe allergic asthma and allergic comorbidities: real-life experience from the Czech Anti-IgE Registry.

Conclusions: In the CAR registry, patients with SAA treated with omalizumab showed a significant positive effect of anti-IgE therapy not only on the asthma control, but also on allergic comorbidities. PMID: 30429711 [PubMed] (Source: Advances in Dermatology and Allergology)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2TjpyZV